Also trades as: 0K6R.L (LSE) · $vol 0M

$146.00

+0.13 (+0.09%)

After Hours: $147.85 (+1.85, +1.27%)

Weekly Expected Move ±3.9%

$131 $137 $143 $148 $154

NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 60 · $14.8B mcap · 100M float · 1.28% daily turnover · Short 73% of daily vol

Credit Risk of going bust: lower than 88% of companies Debt: 2.6% of company value Bonds: none of note held by US funds details ▾

Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.30 (down 99.8%), Neurocrine Biosciences, Inc. would be worth roughly what it owes.
Total debt $401.8M against a stock market value of $14.83B.
Distance to default 12.82 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $200.9M (short-term plus half of long-term), stock volatility 34.0%; Altman Z'' 4.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

54.8 / 100

NoneWeakNarrowWide

Primary source: Network Effects · ROIC: 16.0% · 5Y Avg: 10.4%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. NBIX shows a Weak competitive edge (54.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. ROIC of 16.0% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$165

Low

$202

Avg Target

$225

High

Based on 15 analysts since Jul 30, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 32Hold: 5Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$201.73

Analysts15

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-09-29	UBS	—	$208	$214	+6	+52.4%	$140.44
2026-09-11	Morgan Stanley	—	$182	$183	+1	+16.9%	$156.57
2026-09-08	RBC Capital	Brian Abrahams	$195	$198	+3	+27.2%	$155.66
2026-08-13	Bernstein	—	$221	$218	-3	+39.3%	$156.49
2026-08-13	Morgan Stanley	—	$196	$182	-14	+16.3%	$156.49
2026-08-13	Deutsche Bank	—	$190	$165	-25	+5.4%	$156.49
2026-08-03	Wedbush	—	$185	$194	+9	+14.1%	$170.06
2026-08-03	H.C. Wainwright	Andrew Fein	$192	$215	+23	+28.9%	$166.80
2026-08-03	Canaccord Genuity	Sumant Kulkarni	$158	$210	+52	+25.9%	$166.80
2026-07-31	Morgan Stanley	—	$173	$196	+23	+17.1%	$167.38
2026-07-31	Deutsche Bank	David Hoang	Initiated	$190	—	+14.5%	$165.93
2026-07-31	Needham	—	$185	$204	+19	+10.0%	$185.50
2026-07-31	Piper Sandler	GAAP EPS	$207	$210	+3	+13.2%	$185.50
2026-07-31	Robert W. Baird	Brian Skorney	$150	$225	+75	+21.3%	$185.50
2026-07-31	Guggenheim	—	$200	$222	+22	+19.7%	$185.50
2026-07-21	Guggenheim	—	$175	$200	+25	+12.3%	$178.10
2026-07-17	Wells Fargo	—	$170	$200	+30	+16.6%	$171.55
2026-07-13	Truist Financial	—	$140	$200	+60	+14.2%	$175.16
2026-07-13	BMO Capital	—	$147	$170	+23	-2.2%	$173.89
2026-07-13	Wedbush	—	$151	$185	+34	+6.5%	$173.73
2026-07-07	RBC Capital	Brian Abrahams	$177	$195	+18	+12.0%	$174.10
2026-06-30	UBS	—	$178	$208	+30	+22.4%	$170.00
2026-06-02	Goldman Sachs	Corinne Johnson	Initiated	$213	—	+32.3%	$161.00
2026-05-21	Bernstein	Jeffrey Walch	Initiated	$221	—	+42.1%	$155.50
2026-05-06	Oppenheimer	—	$220	$230	+10	+70.3%	$135.06
2026-05-06	Piper Sandler	—	$179	$207	+28	+53.3%	$135.06
2026-04-06	Oppenheimer	—	$192	$220	+28	+66.1%	$132.48
2026-03-10	Cantor Fitzgerald	Josh Schimmer	$123	$195	+72	+49.6%	$130.39
2026-02-23	Wolfe Research	—	Initiated	$160	—	+24.6%	$128.38
2026-02-17	Truist Financial	Danielle Brill	$169	$140	-29	+8.5%	$128.98
2026-02-12	Needham	—	$184	$185	+1	+47.6%	$125.38
2026-02-12	RBC Capital	—	$180	$177	-3	+42.6%	$124.16
2026-02-12	Wedbush	—	$112	$151	+39	+20.7%	$125.09
2026-02-12	Morgan Stanley	—	$175	$173	-2	+37.3%	$126.04
2026-02-12	H.C. Wainwright	—	$198	$192	-6	+39.7%	$137.44
2026-01-23	UBS	—	$188	$178	-10	+29.6%	$137.37
2026-01-08	Truist Financial	—	$172	$169	-3	+20.2%	$140.62
2026-01-08	Morgan Stanley	—	$168	$175	+7	+24.4%	$140.62
2026-01-05	UBS	Ashwani Verma	$183	$188	+5	+37.1%	$137.15
2025-12-17	H.C. Wainwright	—	$168	$198	+30	+33.1%	$148.74
2025-12-11	Stifel Nicolaus	—	$183	$188	+5	+21.5%	$154.68
2025-12-08	RBC Capital	—	$160	$180	+20	+12.9%	$159.43
2025-10-29	Truist Financial	Danielle Brill	Initiated	$172	—	+22.9%	$139.90
2025-10-29	UBS	—	$195	$183	-12	+33.6%	$136.98
2025-10-29	RBC Capital	—	$136	$160	+24	+16.8%	$136.98
2025-10-29	Mizuho Securities	—	Initiated	$146	—	+3.7%	$140.78
2025-10-29	Stifel Nicolaus	Paul Matteis	$136	$183	+47	+27.9%	$143.09
2025-10-29	BMO Capital	—	$121	$147	+26	+8.3%	$135.72
2025-10-29	Needham	Ami Fadia	Initiated	$184	—	+24.8%	$147.38
2025-10-29	Piper Sandler	—	$159	$179	+20	+21.5%	$147.38

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. NBIX receives an overall rating of A. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: P/E (2/5), P/B (2/5).

Rating Change History

Date	From	To
2026-10-12	A-	A
2026-10-01	A	A-
2026-08-03	A-	A
2026-07-31	A	A-
2026-05-05	A-	A
2026-02-17	C	A-
2026-02-11	A-	C
2026-01-03	B+	A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 82 Grade A+

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

100

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. NBIX scores highest in Safety (100/100) and lowest in Value (41/100). An overall grade of A+ places NBIX among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

7.85

Safe Zone

Piotroski F-Score

6/9

✓ ✓ ✓ ✓ ✓ ✗ ✗ ✗ ✓

Beneish M-Score

-1.96

Unlikely Manipulator

Ohlson O-Score

-10.20

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AAA

Score: 97.0/100

Trend: Improving

Earnings Quality

100/100

OCF/NI: 1.27x

Accruals: -4.2%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. NBIX scores 7.85, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. NBIX scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. NBIX's score of -1.96 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. NBIX's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. NBIX receives an estimated rating of AAA (score: 97.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). NBIX's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

20.64x

PEG

0.20x

P/S

4.38x

P/B

3.98x

P/FCF

20.18x

P/OCF

19.55x

EV/EBITDA

19.14x

EV/Revenue

5.21x

EV/EBIT

20.18x

EV/FCF

20.19x

Earnings Yield

4.02%

FCF Yield

4.96%

Shareholder Yield

0.38%

Graham Number

$73.48

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 20.6x earnings, NBIX commands a growth premium. Graham's intrinsic value formula yields $73.48 per share, 99% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.750

NI / EBT

Interest Burden

1.080

EBT / EBIT

EBIT Margin

0.258

EBIT / Rev

Asset Turnover

0.730

Rev / Assets

Equity Multiplier

1.448

Assets / Equity

ROE

22.1%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. NBIX's ROE of 22.1% is driven by Asset Turnover (0.730), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$260.67

Price/Value

0.65x

Margin of Safety

35.34%

Premium

-35.34%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with NBIX's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. NBIX actually compounded EPS at 56.7% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. NBIX trades at a -35% premium to its adjusted intrinsic value of $260.67, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 20.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$146.08

Median 1Y

$145.04

5th Pctile

$80.53

95th Pctile

$260.82

Ann. Volatility

36.2%

Analyst Target

$201.73

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Matthew C. Abernethy Chief Financial Officer	$920,000	$5,750,023	$13,448,935
Sanjay Keswani, M.D. Chief Medical Officer Jude Onyia, Ph.D. Chief Scientific Officer	$379,167	$4,000,120	$9,007,803
Eiry W. Roberts, M.D.	$720,520	$2,999,925	$7,410,769
Eric Benevich Commercial ercial Officer	$725,913	$2,499,918	$6,311,912

CEO Pay Ratio

15:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $8,535,422

Avg Employee Cost (SGA/emp): $578,100

Employees: 2,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

2,000

+11.1% YoY

Revenue / Employee

$1,430,250

Rev: $2,860,500,000

Profit / Employee

$239,300

NI: $478,600,000

SGA / Employee

$578,100

Avg labor cost proxy

R&D / Employee

$507,850

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	41.4%	7.2%	5.5%	0.9%	4.0%	10.0%	4.2%	10.8%	10.8%	12.7%	18.2%	15.6%	16.3%	14.2%	12.4%	13.4%	15.0%	16.4%	22.5%	22.1%	22.09%
ROA	25.3%	4.7%	3.6%	0.6%	2.8%	7.0%	2.8%	7.6%	7.7%	8.9%	12.7%	11.5%	12.1%	9.8%	8.5%	9.7%	11.0%	11.5%	15.6%	15.3%	15.26%
ROIC	58.7%	8.2%	4.6%	5.2%	7.7%	18.3%	9.0%	9.8%	13.1%	11.6%	21.7%	23.6%	24.6%	20.4%	15.9%	15.2%	13.4%	19.2%	22.3%	16.0%	15.97%
ROCE	10.3%	7.0%	6.2%	1.9%	5.7%	12.1%	4.8%	11.7%	13.0%	13.9%	20.6%	20.4%	20.5%	19.1%	16.8%	15.8%	17.5%	17.7%	20.9%	19.4%	19.42%
Gross Margin	98.6%	98.7%	98.5%	98.7%	98.4%	98.1%	98.0%	97.5%	97.8%	98.4%	98.5%	98.4%	98.7%	98.5%	98.4%	98.4%	98.2%	97.8%	98.3%	97.6%	97.58%
Operating Margin	15.0%	-11.6%	1.0%	14.5%	22.6%	25.1%	-27.2%	16.3%	28.3%	29.2%	19.3%	24.6%	29.5%	22.6%	4.1%	21.2%	30.1%	26.2%	22.8%	16.0%	15.95%
Net Margin	7.6%	-2.3%	4.5%	-4.5%	17.7%	21.6%	-18.2%	21.1%	16.7%	28.7%	8.4%	11.0%	20.9%	16.4%	1.4%	15.6%	26.4%	19.1%	24.3%	15.1%	15.06%
EBITDA Margin	13.5%	-1.3%	8.8%	-4.5%	26.6%	30.0%	-23.1%	28.0%	29.4%	39.8%	21.6%	26.3%	30.8%	28.9%	5.5%	22.2%	37.7%	29.2%	23.7%	19.8%	19.80%
FCF Margin	30.1%	20.6%	8.5%	10.2%	12.7%	21.7%	14.8%	16.8%	21.6%	19.2%	31.0%	23.3%	19.6%	23.7%	20.4%	21.1%	22.1%	26.2%	26.8%	25.8%	25.80%
OCF Margin	31.9%	22.6%	10.7%	12.6%	14.4%	22.8%	15.9%	17.7%	22.9%	20.7%	32.6%	25.0%	21.2%	25.3%	22.0%	22.6%	23.7%	27.4%	27.8%	26.6%	26.62%
ROE 3Y Avg	snapshot only																				15.18%
ROE 5Y Avg	snapshot only																				11.18%
ROA 3Y Avg	snapshot only																				10.79%
ROIC 3Y Avg	snapshot only																				11.82%
ROIC Economic	snapshot only																				14.70%
Cash ROA	snapshot only																				16.76%
Cash ROIC	snapshot only																				24.24%
CROIC	snapshot only																				23.49%
NOPAT Margin	snapshot only																				17.55%
Pretax Margin	snapshot only																				27.87%
R&D / Revenue	snapshot only																				33.53%
SGA / Revenue	snapshot only																				40.06%
SBC / Revenue	snapshot only																				6.95%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	21.07	90.21	128.15	763.86	180.67	77.93	153.57	53.56	59.55	53.98	38.65	42.17	31.14	41.15	37.07	36.45	33.62	30.38	20.37	24.89	20.640
P/S Ratio	8.76	7.13	7.58	7.19	7.57	8.09	6.15	5.65	6.38	7.14	7.21	6.75	5.36	5.96	4.70	5.06	5.36	5.08	4.39	5.21	4.384
P/B Ratio	6.96	5.88	6.58	6.55	6.81	7.05	5.83	5.10	5.68	6.04	5.99	5.70	4.42	5.42	4.47	4.71	4.79	4.47	4.00	4.75	3.979
P/FCF	29.08	34.67	89.53	70.28	59.41	37.29	41.42	33.65	29.57	37.28	23.26	28.92	27.31	25.21	23.03	24.01	24.26	19.42	16.39	20.18	20.177
P/OCF	27.46	31.51	71.10	56.96	52.42	35.47	38.59	31.90	27.78	34.57	22.14	26.97	25.23	23.59	21.39	22.38	22.60	18.57	15.77	19.55	19.554
EV/EBITDA	46.61	56.57	69.34	195.18	91.57	47.82	82.01	34.17	35.22	33.78	23.04	21.86	16.65	20.99	19.38	21.82	21.31	18.74	14.43	19.14	19.142
EV/Revenue	8.45	6.89	7.42	6.89	7.19	7.60	5.75	5.23	5.92	6.82	6.86	6.38	4.92	5.70	4.49	4.84	5.29	4.71	4.10	5.21	5.209
EV/EBIT	49.17	61.41	76.24	272.54	105.29	51.19	96.98	36.84	37.74	35.78	23.95	22.77	17.32	21.91	20.42	23.00	22.31	19.55	14.93	20.18	20.181
EV/FCF	28.06	33.51	87.72	67.42	56.39	35.04	38.74	31.16	27.43	35.61	22.12	27.34	25.09	24.09	22.02	23.00	23.91	17.99	15.29	20.19	20.191
Earnings Yield	4.7%	1.1%	0.8%	0.1%	0.6%	1.3%	0.7%	1.9%	1.7%	1.9%	2.6%	2.4%	3.2%	2.4%	2.7%	2.7%	3.0%	3.3%	4.9%	4.0%	4.02%
FCF Yield	3.4%	2.9%	1.1%	1.4%	1.7%	2.7%	2.4%	3.0%	3.4%	2.7%	4.3%	3.5%	3.7%	4.0%	4.3%	4.2%	4.1%	5.2%	6.1%	5.0%	4.96%
PEG Ratio	snapshot only																				0.201
Price/Tangible Book	snapshot only																				18.161
EV/OCF	snapshot only																				19.568
EV/Gross Profit	snapshot only																				5.317
Acquirers Multiple	snapshot only																				22.276
Shareholder Yield	snapshot only																				0.38%
Graham Number	snapshot only																				$73.48

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	4.45	3.96	4.02	3.57	2.49	2.70	3.83	2.57	2.39	2.45	2.52	4.19	4.37	3.40	3.13	3.20	3.38	3.39	2.93	1.87	1.872
Quick Ratio	4.34	3.83	3.90	3.47	2.41	2.64	3.74	2.51	2.34	2.40	2.47	4.08	4.26	3.28	3.02	3.10	3.27	3.30	2.85	1.75	1.753
Debt/Equity	0.32	0.32	0.35	0.19	0.17	0.15	0.15	0.15	0.14	0.19	0.21	0.10	0.09	0.18	0.18	0.16	0.30	0.13	0.12	0.11	0.109
Net Debt/Equity	-0.24	-0.20	-0.13	-0.27	-0.35	-0.43	-0.38	-0.38	-0.41	-0.27	-0.29	-0.31	-0.36	-0.24	-0.20	-0.20	-0.07	-0.33	-0.27	0.00	0.003
Debt/Assets	0.22	0.21	0.22	0.13	0.12	0.11	0.11	0.11	0.10	0.13	0.15	0.08	0.07	0.12	0.12	0.11	0.21	0.09	0.08	0.07	0.075
Debt/EBITDA	2.25	3.19	3.71	5.86	2.44	1.11	2.32	1.08	0.91	1.12	0.87	0.41	0.38	0.71	0.80	0.79	1.36	0.58	0.46	0.44	0.438
Net Debt/EBITDA	-1.69	-1.96	-1.43	-8.29	-4.90	-3.07	-5.66	-2.74	-2.74	-1.58	-1.18	-1.27	-1.47	-0.97	-0.89	-0.96	-0.31	-1.48	-1.03	0.01	0.013
Interest Coverage	6.81	4.93	5.35	1.82	7.52	31.13	16.93	50.53	60.78	78.24	123.35	11.20	12.28	12.06	10.68	—	—	—	—	300.28	300.276
Equity Multiplier	1.50	1.51	1.54	1.41	1.39	1.39	1.40	1.41	1.42	1.46	1.46	1.32	1.30	1.44	1.45	1.44	1.42	1.42	1.44	1.45	1.451
Cash Ratio	snapshot only																				0.446
Debt Service Coverage	snapshot only																				316.586
Cash to Debt	snapshot only																				0.970
FCF to Debt	snapshot only																				2.166
Defensive Interval	snapshot only																				185.2 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.61	0.60	0.61	0.65	0.67	0.67	0.71	0.72	0.71	0.67	0.68	0.72	0.70	0.68	0.67	0.70	0.69	0.69	0.72	0.73	0.730
Inventory Turnover	0.57	0.49	0.54	0.61	0.63	0.71	0.87	1.11	1.18	1.08	1.10	0.98	0.89	0.71	0.74	0.76	0.76	0.82	0.92	0.85	0.852
Receivables Turnover	6.67	6.62	5.87	5.93	5.97	5.56	4.88	5.02	4.96	4.78	4.71	4.95	4.99	5.13	4.99	4.72	4.44	4.91	4.83	4.55	4.551
Payables Turnover	—	0.31	—	—	—	0.39	—	—	0.83	0.40	0.89	0.68	0.35	0.28	0.36	0.36	0.41	0.48	0.49	0.56	0.556
DSO	55	55	62	62	61	66	75	73	74	76	78	74	73	71	73	77	82	74	76	80	80.2 days
DIO	642	747	674	594	582	516	420	329	309	337	333	372	410	514	492	480	480	443	398	429	428.6 days
DPO	0	1160	0	0	0	935	0	0	440	922	412	537	1042	1306	1009	1023	898	753	740	656	656.0 days
Cash Conversion Cycle	697	-358	736	655	643	-353	495	402	-58	-508	-1	-92	-558	-721	-443	-465	-336	-236	-267	-147	-147.3 days
Fixed Asset Turnover	snapshot only																				6.265
Operating Cycle	snapshot only																				508.8 days
Cash Velocity	snapshot only																				8.655
Capital Intensity	snapshot only																				1.588

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	2.6%	8.4%	15.5%	25.7%	29.9%	31.3%	32.4%	29.0%	28.5%	26.8%	24.0%	26.7%	25.7%	24.8%	21.7%	18.4%	19.6%	21.4%	28.6%	34.4%	34.42%
Net Income	3.8%	-78.0%	-82.2%	-96.7%	-86.9%	72.4%	-10.4%	13.5%	2.3%	61.6%	4.8%	92.3%	1.0%	36.7%	-17.3%	2.7%	10.9%	40.2%	1.2%	1.0%	1.03%
EPS	3.5%	-77.5%	-82.1%	-96.6%	-87.1%	62.3%	-9.9%	12.8%	2.2%	59.2%	4.4%	85.4%	95.8%	35.9%	-16.4%	5.6%	12.9%	40.8%	1.2%	96.3%	96.33%
FCF	41.7%	10.0%	-60.8%	-45.9%	-45.1%	38.5%	1.3%	1.1%	1.2%	12.0%	1.6%	76.1%	14.4%	54.1%	-19.9%	6.9%	34.8%	34.4%	68.9%	64.6%	64.63%
EBITDA	33.6%	-6.8%	-4.2%	-57.5%	-43.8%	71.3%	-13.3%	4.6%	1.7%	61.1%	4.3%	1.4%	1.2%	67.8%	-5.2%	-9.9%	0.4%	12.4%	57.5%	64.8%	64.77%
Op. Income	50.5%	-37.1%	-45.4%	-45.8%	-48.1%	1.4%	77.7%	1.3%	86.6%	0.8%	2.5%	2.6%	1.8%	1.3%	6.5%	-7.7%	-4.9%	8.5%	57.9%	59.4%	59.37%
OCF Growth	snapshot only																				58.31%
Asset Growth	snapshot only																				37.77%
Equity Growth	snapshot only																				37.09%
Debt Growth	snapshot only																				-8.49%
Shares Change	snapshot only																				3.17%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	37.2%	35.9%	32.5%	28.9%	27.2%	23.6%	21.7%	18.5%	19.6%	21.7%	23.8%	27.1%	28.0%	27.6%	26.0%	24.6%	24.5%	24.3%	24.7%	26.3%	26.34%
Revenue 5Y	1.3%	1.4%	—	1.9%	83.3%	55.9%	47.0%	38.9%	33.9%	33.1%	30.8%	28.5%	27.1%	24.5%	22.2%	20.1%	20.8%	22.3%	24.3%	26.7%	26.74%
EPS 3Y	2.5%	62.4%	—	-12.5%	38.9%	59.1%	-28.7%	-5.5%	23.6%	-16.5%	-4.5%	-4.4%	-6.7%	52.0%	59.8%	2.0%	92.2%	45.0%	1.1%	56.7%	56.67%
EPS 5Y	—	—	—	—	—	—	—	—	79.1%	61.7%	—	76.5%	75.9%	54.2%	10.4%	10.6%	33.1%	2.2%	9.6%	12.6%	12.65%
Net Income 3Y	2.6%	61.9%	—	-12.3%	40.3%	61.0%	-28.7%	-4.9%	26.9%	-15.0%	-2.8%	-2.4%	-4.6%	56.2%	62.4%	2.1%	94.5%	45.8%	1.2%	58.7%	58.73%
Net Income 5Y	—	—	—	—	—	—	—	—	80.7%	63.9%	—	79.8%	78.8%	55.9%	11.6%	11.2%	35.6%	3.3%	10.7%	14.1%	14.11%
EBITDA 3Y	64.5%	34.8%	—	-6.5%	18.8%	40.1%	-21.1%	-0.5%	27.3%	37.0%	63.5%	79.1%	50.6%	66.7%	63.0%	1.3%	82.8%	44.9%	98.8%	53.1%	53.07%
EBITDA 5Y	—	—	—	—	—	—	—	—	47.1%	46.5%	—	61.6%	59.1%	49.4%	19.6%	16.5%	35.6%	37.2%	45.5%	53.5%	53.51%
Gross Profit 3Y	37.1%	35.9%	32.4%	28.7%	27.0%	23.4%	21.4%	18.0%	19.1%	21.3%	23.4%	26.9%	27.9%	27.5%	25.9%	24.6%	24.5%	24.2%	24.7%	26.3%	26.34%
Gross Profit 5Y	—	—	—	1.9%	83.1%	55.7%	46.8%	38.6%	33.6%	32.9%	30.5%	28.3%	27.0%	24.4%	22.0%	19.9%	20.6%	22.1%	24.1%	26.5%	26.50%
Op. Income 3Y	98.7%	40.6%	—	90.2%	34.1%	51.1%	-17.2%	-18.1%	13.4%	15.5%	50.7%	63.9%	40.1%	77.2%	88.3%	95.7%	71.4%	35.5%	81.0%	73.7%	73.67%
Op. Income 5Y	—	—	—	—	—	—	—	—	50.0%	46.7%	—	1.2%	66.4%	51.2%	16.3%	12.5%	31.5%	30.6%	41.9%	45.3%	45.30%
FCF 3Y	66.1%	44.9%	5.2%	44.1%	29.2%	33.0%	-6.2%	-6.4%	19.2%	19.5%	33.1%	26.3%	11.0%	33.7%	68.9%	58.6%	49.6%	32.4%	51.9%	45.8%	45.81%
FCF 5Y	—	—	—	—	—	—	—	1.8%	40.5%	36.4%	3.3%	62.0%	39.9%	32.3%	11.3%	9.1%	21.1%	28.7%	26.1%	28.8%	28.83%
OCF 3Y	55.1%	36.3%	67.6%	32.0%	26.1%	30.7%	-5.3%	-5.8%	20.1%	20.5%	32.9%	27.0%	11.8%	32.4%	60.3%	51.4%	47.0%	32.1%	50.2%	44.7%	44.74%
OCF 5Y	—	—	—	—	—	—	—	86.1%	34.9%	30.9%	88.2%	49.5%	36.7%	31.4%	12.0%	9.8%	21.9%	28.6%	25.7%	28.2%	28.23%
Assets 3Y	29.3%	27.8%	30.8%	23.4%	22.0%	22.0%	20.1%	19.9%	23.8%	23.3%	23.4%	19.1%	20.6%	21.5%	19.8%	24.7%	25.8%	25.0%	27.6%	27.1%	27.05%
Assets 5Y	38.3%	41.5%	49.3%	21.6%	22.6%	23.7%	24.0%	25.4%	25.0%	26.8%	29.4%	25.4%	24.5%	23.3%	22.0%	20.7%	23.2%	21.7%	21.6%	22.3%	22.33%
Equity 3Y	44.3%	41.9%	50.4%	43.3%	39.1%	38.9%	34.0%	30.6%	35.5%	25.6%	25.6%	25.2%	26.4%	23.5%	22.2%	23.7%	24.8%	24.0%	26.5%	25.9%	25.85%
Book Value 3Y	43.9%	42.3%	46.9%	42.9%	37.7%	37.3%	33.9%	29.8%	31.9%	23.5%	23.3%	22.6%	23.7%	20.2%	20.2%	21.5%	23.4%	23.3%	23.8%	24.2%	24.22%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.97	0.98	0.98	0.96	0.97	0.98	0.98	0.96	0.96	0.98	0.98	0.97	0.96	0.95	0.96	0.95	0.95	0.96	0.96	0.96	0.957
Earnings Stability	0.79	0.56	0.58	0.46	0.46	0.36	0.18	0.19	0.20	0.18	0.17	0.17	0.27	0.17	0.04	0.10	0.25	0.19	0.30	0.44	0.442
Margin Stability	0.44	0.44	1.00	1.00	1.00	1.00	1.00	1.00	0.99	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.996
Rev. Growth Consistency	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	1.00	0.00	0.00	0.00	0.00	0.50	0.00	0.50	0.50	1.00	0.50	1.00	1.00	1.00	0.00	1.00	1.00	1.00	0.50	1.00	1.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.50	0.50	0.50	0.50	0.50	0.50	0.96	0.50	0.50	0.50	0.50	0.50	0.50	0.85	0.93	0.99	0.96	0.84	0.50	0.50	0.500
Earnings Smoothness	0.00	0.00	0.00	0.00	0.00	0.47	0.89	0.00	0.00	0.53	0.00	0.37	0.32	0.69	0.81	0.97	0.90	0.67	0.26	0.32	0.322
ROE Trend	0.25	-0.14	-0.24	-0.26	-0.19	-0.12	-0.15	-0.05	-0.09	0.03	0.11	0.08	0.08	0.03	0.02	0.01	0.02	0.03	0.06	0.06	0.059
Gross Margin Trend	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.01	-0.01	-0.01	-0.01	-0.00	-0.00	0.00	0.00	0.00	0.00	0.00	-0.00	-0.00	-0.00	-0.004
FCF Margin Trend	0.13	0.02	-0.20	-0.19	-0.13	0.01	-0.02	-0.00	0.00	-0.02	0.19	0.10	0.02	0.03	-0.03	0.01	0.02	0.05	0.01	0.04	0.036
Sustainable Growth Rate	41.4%	7.2%	5.5%	0.9%	4.0%	10.0%	4.2%	10.8%	10.8%	12.7%	18.2%	15.6%	16.3%	14.2%	12.4%	13.4%	15.0%	16.4%	22.5%	22.1%	22.09%
Internal Growth Rate	33.8%	4.9%	3.7%	0.6%	2.9%	7.5%	2.9%	8.3%	8.3%	9.8%	14.5%	12.9%	13.8%	10.9%	9.3%	10.7%	12.3%	12.9%	18.4%	18.0%	18.00%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	0.77	2.86	1.80	13.41	3.45	2.20	3.98	1.68	2.14	1.56	1.75	1.56	1.23	1.74	1.73	1.63	1.49	1.64	1.29	1.27	1.273
FCF/OCF	0.94	0.91	0.79	0.81	0.88	0.95	0.93	0.95	0.94	0.93	0.95	0.93	0.92	0.94	0.93	0.93	0.93	0.96	0.96	0.97	0.969
FCF/Net Income	snapshot only																				1.234
OCF/EBITDA	snapshot only																				0.978
CapEx/Revenue	1.8%	2.1%	2.2%	2.4%	1.7%	1.1%	1.1%	0.9%	1.4%	1.5%	1.6%	1.7%	1.6%	1.6%	1.6%	1.5%	1.6%	1.2%	1.0%	0.8%	0.82%
CapEx/Depreciation	snapshot only																				0.586
Accruals Ratio	0.06	-0.09	-0.03	-0.08	-0.07	-0.08	-0.08	-0.05	-0.09	-0.05	-0.09	-0.06	-0.03	-0.07	-0.06	-0.06	-0.05	-0.07	-0.05	-0.04	-0.042
Sloan Accruals	snapshot only																				-0.105
Cash Flow Adequacy	snapshot only																				32.422
Earnings Quality Score	snapshot only																				1.000

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	87.9%	1.5%	1.3%	1.1%	35.0%	10.7%	9.4%	9.36%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	2.1%	4.0%	3.7%	3.3%	1.2%	0.5%	0.4%	0.38%
Net Buyback Yield	-0.4%	-0.3%	-0.2%	-0.2%	-0.2%	-0.4%	-0.5%	-0.5%	-0.5%	-0.5%	-0.9%	-1.0%	-1.2%	1.3%	3.2%	3.0%	2.5%	0.3%	-0.4%	-0.7%	-0.71%
Total Shareholder Return	-0.4%	-0.3%	-0.2%	-0.2%	-0.2%	-0.4%	-0.5%	-0.5%	-0.5%	-0.5%	-0.9%	-1.0%	-1.2%	1.3%	3.2%	3.0%	2.5%	0.3%	-0.4%	-0.7%	-0.71%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	2.83	0.88	0.75	0.82	0.71	0.72	0.72	0.75	0.76	0.75	0.79	0.76	0.74	0.70	0.66	0.66	0.68	0.68	0.71	0.75	0.750
Interest Burden (EBT/EBIT)	0.85	0.80	0.81	0.45	0.87	0.97	0.94	0.99	0.90	0.92	0.83	0.75	0.82	0.79	0.88	1.00	0.99	1.02	1.10	1.08	1.080
EBIT Margin	0.17	0.11	0.10	0.03	0.07	0.15	0.06	0.14	0.16	0.19	0.29	0.28	0.28	0.26	0.22	0.21	0.24	0.24	0.27	0.26	0.258
Asset Turnover	0.61	0.60	0.61	0.65	0.67	0.67	0.71	0.72	0.71	0.67	0.68	0.72	0.70	0.68	0.67	0.70	0.69	0.69	0.72	0.73	0.730
Equity Multiplier	1.64	1.52	1.54	1.47	1.44	1.44	1.46	1.41	1.41	1.43	1.43	1.36	1.35	1.45	1.45	1.38	1.36	1.43	1.45	1.45	1.448

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$4.55	$0.94	$0.73	$0.13	$0.59	$1.53	$0.66	$1.76	$1.89	$2.44	$3.57	$3.26	$3.70	$3.32	$2.98	$3.45	$4.18	$4.67	$6.47	$6.77	$6.77
Book Value/Share	$13.78	$14.48	$14.25	$14.89	$15.60	$16.94	$17.35	$18.49	$19.80	$21.82	$23.03	$24.15	$26.07	$25.17	$24.74	$26.68	$29.30	$31.74	$32.95	$35.45	$36.57
Tangible Book/Share	$13.78	$14.48	$14.25	$14.89	$15.60	$16.57	$16.96	$18.12	$19.46	$21.47	$22.70	$23.83	$25.74	$24.76	$24.38	$26.31	$28.96	$31.74	$32.95	$9.28	$9.28
Revenue/Share	$10.95	$11.94	$12.37	$13.56	$14.03	$14.77	$16.46	$16.70	$17.64	$18.45	$19.13	$20.40	$21.50	$22.89	$23.54	$24.85	$26.17	$27.91	$30.00	$32.38	$33.40
FCF/Share	$3.30	$2.46	$1.05	$1.39	$1.79	$3.20	$2.44	$2.80	$3.81	$3.53	$5.93	$4.76	$4.22	$5.41	$4.80	$5.23	$5.79	$7.30	$8.04	$8.35	$8.62
OCF/Share	$3.49	$2.70	$1.32	$1.71	$2.03	$3.37	$2.62	$2.96	$4.05	$3.81	$6.23	$5.10	$4.57	$5.79	$5.17	$5.62	$6.21	$7.64	$8.35	$8.62	$8.89
Cash/Share	$7.84	$7.50	$6.81	$6.78	$8.07	$9.81	$9.21	$9.75	$10.83	$10.08	$11.69	$10.00	$11.77	$10.46	$9.20	$9.66	$10.88	$14.44	$12.73	$3.74	$3.86
EBITDA/Share	$1.99	$1.46	$1.32	$0.48	$1.10	$2.35	$1.15	$2.55	$2.96	$3.73	$5.69	$5.95	$6.36	$6.22	$5.46	$5.52	$6.49	$7.02	$8.52	$8.81	$8.81
Debt/Share	$4.47	$4.64	$4.92	$2.81	$2.68	$2.61	$2.68	$2.76	$2.71	$4.19	$4.94	$2.47	$2.41	$4.42	$4.37	$4.35	$8.86	$4.05	$3.93	$3.86	$3.86
Net Debt/Share	$-3.37	$-2.85	$-1.89	$-3.97	$-5.39	$-7.21	$-6.54	$-6.99	$-8.13	$-5.90	$-6.74	$-7.53	$-9.36	$-6.03	$-4.84	$-5.31	$-2.02	$-10.39	$-8.80	$0.12	$0.12

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	7.852
Altman Z-Prime	snapshot only																				13.538
Piotroski F-Score	5	5	6	6	5	6	6	6	6	6	6	8	8	8	7	5	6	7	6	6	6
Beneish M-Score	-1.42	-2.52	-1.84	-2.16	-2.17	-2.22	-2.51	-2.33	-2.40	-2.27	-2.51	-2.43	-2.37	-2.70	-2.61	-2.45	-2.24	-2.37	-2.13	-1.96	-1.962
Ohlson O-Score	snapshot only																				-10.202
ROIC (Greenblatt)	snapshot only																				66.91%
Net-Net WC	snapshot only																				$-0.27
EVA	snapshot only																				$221408676.88

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AAA
Credit Score	84.45	80.38	83.67	74.54	89.21	96.35	92.43	95.94	97.00	95.65	95.99	94.82	94.41	94.73	94.63	94.60	92.29	94.54	94.35	96.98	96.982
Credit Grade	snapshot only																				1
Credit Trend	snapshot only																				2.382
Implied Spread (bps)	snapshot only																				50.000
Industry Credit Rank	snapshot only																				96
Sector Credit Rank	snapshot only																				92

NBIX NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet